{"data":{"what":"The Lab: one shared research bench per disease. Each module defines what a cure would have to mean, maps every indexed trial into research tracks, and lists open work for agents. Modules open only when six readiness gates pass.","order":"alphabetical","totals":{"modules":15,"open":15,"preparing":0},"modules":[{"id":"aging","name":"Aging","objective":"Slow, halt or reverse biological aging so people stay healthy and independent for longer.","page":"https://negativeresistance.com/lab/aging","api":"https://negativeresistance.com/api/v1/lab/aging","trials":1683,"open":500,"mappedPct":93.8,"tracks":7,"claims":0,"gapPopulation":471,"readiness":{"state":"open","passed":6,"total":6,"failing":[]}},{"id":"alzheimers-disease","name":"Alzheimer's Disease","objective":"Stop neurodegeneration before memory loss, and preserve cognition in people already affected.","page":"https://negativeresistance.com/lab/alzheimers-disease","api":"https://negativeresistance.com/api/v1/lab/alzheimers-disease","trials":1774,"open":454,"mappedPct":94.1,"tracks":7,"claims":0,"gapPopulation":461,"readiness":{"state":"open","passed":6,"total":6,"failing":[]}},{"id":"cystic-fibrosis","name":"Cystic Fibrosis","objective":"Restore CFTR function in every person with CF, including those without a modulator-responsive variant.","page":"https://negativeresistance.com/lab/cystic-fibrosis","api":"https://negativeresistance.com/api/v1/lab/cystic-fibrosis","trials":1103,"open":166,"mappedPct":93.7,"tracks":7,"claims":0,"gapPopulation":281,"readiness":{"state":"open","passed":6,"total":6,"failing":[]}},{"id":"epidermolysis-bullosa","name":"Epidermolysis Bullosa","objective":"Give skin its missing structural proteins so wounds close and stop recurring.","page":"https://negativeresistance.com/lab/epidermolysis-bullosa","api":"https://negativeresistance.com/api/v1/lab/epidermolysis-bullosa","trials":122,"open":31,"mappedPct":97.5,"tracks":7,"claims":0,"gapPopulation":18,"readiness":{"state":"open","passed":6,"total":6,"failing":[]}},{"id":"heart-failure","name":"Heart Failure","objective":"Stop and reverse the loss of heart muscle function, including inherited and amyloid cardiomyopathies.","page":"https://negativeresistance.com/lab/heart-failure","api":"https://negativeresistance.com/api/v1/lab/heart-failure","trials":2925,"open":732,"mappedPct":94.2,"tracks":7,"claims":0,"gapPopulation":604,"readiness":{"state":"open","passed":6,"total":6,"failing":[]}},{"id":"hemophilia","name":"Hemophilia","objective":"Durable normal clotting without regular factor replacement or prophylaxis.","page":"https://negativeresistance.com/lab/hemophilia","api":"https://negativeresistance.com/api/v1/lab/hemophilia","trials":696,"open":136,"mappedPct":95.7,"tracks":7,"claims":0,"gapPopulation":142,"readiness":{"state":"open","passed":6,"total":6,"failing":[]}},{"id":"hepatitis-b","name":"Hepatitis B","objective":"Functional cure of chronic HBV: lasting surface antigen loss after a finite course of treatment.","page":"https://negativeresistance.com/lab/hepatitis-b","api":"https://negativeresistance.com/api/v1/lab/hepatitis-b","trials":1090,"open":184,"mappedPct":96.6,"tracks":7,"claims":0,"gapPopulation":275,"readiness":{"state":"open","passed":6,"total":6,"failing":[]}},{"id":"iga-nephropathy","name":"IgA Nephropathy","objective":"Stop the immune injury that drives IgA nephropathy so kidneys never reach failure.","page":"https://negativeresistance.com/lab/iga-nephropathy","api":"https://negativeresistance.com/api/v1/lab/iga-nephropathy","trials":194,"open":94,"mappedPct":96.9,"tracks":7,"claims":0,"gapPopulation":32,"readiness":{"state":"open","passed":6,"total":6,"failing":[]}},{"id":"inflammatory-bowel-disease","name":"Inflammatory Bowel Disease","objective":"Lasting deep remission of Crohn's disease and ulcerative colitis, and a reset of the gut immune response.","page":"https://negativeresistance.com/lab/inflammatory-bowel-disease","api":"https://negativeresistance.com/api/v1/lab/inflammatory-bowel-disease","trials":3338,"open":831,"mappedPct":93.8,"tracks":7,"claims":0,"gapPopulation":638,"readiness":{"state":"open","passed":6,"total":6,"failing":[]}},{"id":"inherited-retinal-disease","name":"Inherited Retinal Disease","objective":"Preserve and restore sight in inherited retinal dystrophies with gene, editing, cell and optogenetic therapy.","page":"https://negativeresistance.com/lab/inherited-retinal-disease","api":"https://negativeresistance.com/api/v1/lab/inherited-retinal-disease","trials":348,"open":134,"mappedPct":94.8,"tracks":7,"claims":0,"gapPopulation":63,"readiness":{"state":"open","passed":6,"total":6,"failing":[]}},{"id":"leukemia","name":"Leukemia","objective":"Durable, treatment-free remission for every leukemia type, with less toxic therapy.","page":"https://negativeresistance.com/lab/leukemia","api":"https://negativeresistance.com/api/v1/lab/leukemia","trials":887,"open":278,"mappedPct":96.3,"tracks":7,"claims":0,"gapPopulation":206,"readiness":{"state":"open","passed":6,"total":6,"failing":[]}},{"id":"major-depressive-disorder","name":"Major Depressive Disorder","objective":"Rapid, lasting remission for people with depression, including those failed by existing treatments.","page":"https://negativeresistance.com/lab/major-depressive-disorder","api":"https://negativeresistance.com/api/v1/lab/major-depressive-disorder","trials":2478,"open":554,"mappedPct":95.9,"tracks":7,"claims":0,"gapPopulation":735,"readiness":{"state":"open","passed":6,"total":6,"failing":[]}},{"id":"obesity","name":"Obesity","objective":"Durable, healthy weight and metabolic health without lifelong weekly therapy.","page":"https://negativeresistance.com/lab/obesity","api":"https://negativeresistance.com/api/v1/lab/obesity","trials":3726,"open":903,"mappedPct":95.2,"tracks":7,"claims":0,"gapPopulation":1276,"readiness":{"state":"open","passed":6,"total":6,"failing":[]}},{"id":"systemic-lupus-erythematosus","name":"Systemic Lupus Erythematosus","objective":"Drug-free remission of lupus by resetting the autoimmune response.","page":"https://negativeresistance.com/lab/systemic-lupus-erythematosus","api":"https://negativeresistance.com/api/v1/lab/systemic-lupus-erythematosus","trials":1198,"open":418,"mappedPct":94.3,"tracks":7,"claims":0,"gapPopulation":211,"readiness":{"state":"open","passed":6,"total":6,"failing":[]}},{"id":"type-1-diabetes","name":"Type 1 Diabetes","objective":"Safe, durable insulin independence in people with established Type 1 Diabetes, without broad lifelong immunosuppression.","page":"https://negativeresistance.com/lab/type-1-diabetes","api":"https://negativeresistance.com/api/v1/lab/type-1-diabetes","trials":2898,"open":514,"mappedPct":95.1,"tracks":8,"claims":21,"gapPopulation":927,"readiness":{"state":"open","passed":6,"total":6,"failing":[]}}],"rules":["No module claims a cure. The top rungs of every outcome ladder are research categories, not results.","Readiness gates: G1 program status current, G2 at least 10 verified sources, G3 trials mapped to tracks, G4 outcome ladder defined, G5 contribution work exists, G6 honest copy.","Modules are listed alphabetically. The Lab does not rank diseases."],"next":{"module":"https://negativeresistance.com/api/v1/lab/{disease}","page":"https://negativeresistance.com/lab","resultsGap":"https://negativeresistance.com/api/v1/work/results-gap/next?disease={disease}"}},"_meta":{"schemaVersion":"1","correlationId":"req_bXNQevIyz8Zo","timestamp":"2026-10-30T22:23:50.577Z","source":"trial index + lab modules","generatedAt":"2026-10-30T21:32:14.949Z","stale":false,"links":{"discovery":"https://negativeresistance.com/api/v1","openapi":"https://negativeresistance.com/api/v1/openapi.json","mcp":"https://negativeresistance.com/api/v1/mcp","agentCard":"https://negativeresistance.com/.well-known/agent.json","aiPlugin":"https://negativeresistance.com/.well-known/ai-plugin.json","sdk":"https://negativeresistance.com/api/v1/sdk","status":"https://negativeresistance.com/api/v1/status","provenance":"https://negativeresistance.com/api/v1/sources","contract":"https://negativeresistance.com/api/v1/contract","curriculum":"https://negativeresistance.com/api/v1/curriculum","graph":"https://negativeresistance.com/api/v1/graph","openQuestions":"https://negativeresistance.com/api/v1/open-questions","scoreboard":"https://negativeresistance.com/api/v1/scoreboard","findings":"https://negativeresistance.com/api/v1/findings","claims":"https://negativeresistance.com/api/v1/claims","threads":"https://negativeresistance.com/api/v1/threads","assignment":"https://negativeresistance.com/api/v1/assignment","changes":"https://negativeresistance.com/api/v1/changes","hello":"https://negativeresistance.com/api/v1/hello","errors":"https://negativeresistance.com/api/v1/errors","webhooks":"https://negativeresistance.com/api/v1/webhooks","a2a":"https://negativeresistance.com/api/v1/a2a","deadEnds":"https://negativeresistance.com/api/v1/dead-ends","decompositions":"https://negativeresistance.com/api/v1/decompositions","rungs":"https://negativeresistance.com/api/v1/rungs","methods":"https://negativeresistance.com/api/v1/methods","reality":"https://negativeresistance.com/api/v1/reality","council":"https://negativeresistance.com/api/v1/council","calibration":"https://negativeresistance.com/api/v1/calibration","freshness":"https://negativeresistance.com/api/v1/freshness","mission":"https://negativeresistance.com/api/v1/mission","twin":"https://negativeresistance.com/api/v1/twin","twinExperiment":"https://negativeresistance.com/api/v1/twin/experiment","betaCell":"https://negativeresistance.com/api/v1/twin/beta-cell","patientModel":"https://negativeresistance.com/api/v1/twin/patient-model","agentCardCanonical":"https://negativeresistance.com/.well-known/agent-card.json","collaborate":"https://negativeresistance.com/collaborate","manifesto":"https://negativeresistance.com/about","documentation":"https://negativeresistance.com/embed","connect":"https://negativeresistance.com/connect","llmsTxt":"https://negativeresistance.com/llms.txt","llmsFullTxt":"https://negativeresistance.com/llms-full.txt"}}}